| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 1.67e-07 | 37 | 135 | 6 | GO:0061631 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 4.24e-07 | 43 | 135 | 6 | GO:0061650 | |
| GeneOntologyMolecularFunction | RNA polymerase II activity | 6.36e-07 | 11 | 135 | 4 | GO:0001055 | |
| GeneOntologyMolecularFunction | DNA-directed 5'-3' RNA polymerase activity | 4.78e-05 | 30 | 135 | 4 | GO:0003899 | |
| GeneOntologyMolecularFunction | 5'-3' RNA polymerase activity | 6.20e-05 | 32 | 135 | 4 | GO:0034062 | |
| GeneOntologyMolecularFunction | RNA polymerase activity | 6.20e-05 | 32 | 135 | 4 | GO:0097747 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 7.91e-05 | 152 | 135 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DDX59 VPS72 ATRX POLR2J3 POLR2A POLR2J FANCM THAP9 PNPT1 RECQL5 POLR2J2 PARN CNOT1 | 4.38e-04 | 645 | 135 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | ATPase inhibitor activity | 6.69e-04 | 6 | 135 | 2 | GO:0042030 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 6.69e-04 | 6 | 135 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 7.85e-04 | 27 | 135 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | alpha-(1->3)-fucosyltransferase activity | 1.24e-03 | 8 | 135 | 2 | GO:0046920 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.42e-03 | 33 | 135 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 1.55e-03 | 34 | 135 | 3 | GO:0008266 | |
| GeneOntologyBiologicalProcess | protein K29-linked ubiquitination | 1.13e-06 | 13 | 133 | 4 | GO:0035519 | |
| GeneOntologyBiologicalProcess | protein K27-linked ubiquitination | 1.57e-06 | 14 | 133 | 4 | GO:0044314 | |
| GeneOntologyBiologicalProcess | protein K6-linked ubiquitination | 3.68e-06 | 17 | 133 | 4 | GO:0085020 | |
| GeneOntologyBiologicalProcess | protein K11-linked ubiquitination | 3.82e-06 | 37 | 133 | 5 | GO:0070979 | |
| GeneOntologyCellularComponent | RNA polymerase II, holoenzyme | 1.78e-06 | 89 | 135 | 7 | GO:0016591 | |
| GeneOntologyCellularComponent | RNA polymerase II, core complex | 3.71e-06 | 17 | 135 | 4 | GO:0005665 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 8.76e-06 | 113 | 135 | 7 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 1.04e-05 | 116 | 135 | 7 | GO:0000428 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 1.23e-05 | 119 | 135 | 7 | GO:0030880 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FLNA THEMIS POLR2J3 POLR2A POLR2J RGPD1 FANCM ADAR MEN1 THOC6 PBRM1 PRPF4 ABRAXAS1 NXF5 POLR2J2 SUGP1 UBE2S TAF1 TAF4B TAF10 MGA SEC13 | 7.06e-05 | 1377 | 135 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | transferase complex | VPS72 POLR2J3 POLR2A POLR2J RGPD1 MEN1 UBE2D1 UBE2D2 UBE2D3 UBE2D4 POLR2J2 UBE2S TAF1 TAF4B FUT6 TAF10 MGA | 1.60e-04 | 963 | 135 | 17 | GO:1990234 |
| GeneOntologyCellularComponent | membrane attack complex | 8.51e-04 | 7 | 135 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | MLL1 complex | 1.14e-03 | 32 | 135 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 1.25e-03 | 33 | 135 | 3 | GO:0044665 | |
| Domain | UBQ-conjugating_AS | 7.46e-07 | 25 | 131 | 5 | IPR023313 | |
| Domain | RNA_POL_L_13KD | 1.34e-06 | 4 | 131 | 3 | PS01154 | |
| Domain | RNA_pol_Rpb11_13-16kDa_CS | 1.34e-06 | 4 | 131 | 3 | IPR008193 | |
| Domain | RBP11-like_dimer | 6.64e-06 | 6 | 131 | 3 | IPR009025 | |
| Domain | RNA_pol_L | 6.64e-06 | 6 | 131 | 3 | PF01193 | |
| Domain | UQ_con | 7.48e-06 | 39 | 131 | 5 | PF00179 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 8.50e-06 | 40 | 131 | 5 | PS00183 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 9.62e-06 | 41 | 131 | 5 | PS50127 | |
| Domain | UBQ-conjugat_E2 | 9.62e-06 | 41 | 131 | 5 | IPR000608 | |
| Domain | - | 2.85e-05 | 51 | 131 | 5 | 3.10.110.10 | |
| Domain | UBQ-conjugating_enzyme/RWD | 3.44e-05 | 53 | 131 | 5 | IPR016135 | |
| Domain | IG_FLMN | 3.90e-05 | 10 | 131 | 3 | SM00557 | |
| Domain | FNIP_N_dom | 4.88e-05 | 2 | 131 | 2 | IPR028084 | |
| Domain | FNIP_mid_dom | 4.88e-05 | 2 | 131 | 2 | IPR028085 | |
| Domain | FNIP_C_dom | 4.88e-05 | 2 | 131 | 2 | IPR028086 | |
| Domain | FNIP_C | 4.88e-05 | 2 | 131 | 2 | PF14638 | |
| Domain | FNIP_M | 4.88e-05 | 2 | 131 | 2 | PF14637 | |
| Domain | FNIP_N | 4.88e-05 | 2 | 131 | 2 | PF14636 | |
| Domain | FNIP_fam | 4.88e-05 | 2 | 131 | 2 | IPR026156 | |
| Domain | Filamin | 5.34e-05 | 11 | 131 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 5.34e-05 | 11 | 131 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 5.34e-05 | 11 | 131 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 5.34e-05 | 11 | 131 | 3 | IPR017868 | |
| Domain | RNA_pol_L_2 | 1.46e-04 | 3 | 131 | 2 | PF13656 | |
| Domain | DOCK_N | 4.82e-04 | 5 | 131 | 2 | PF16172 | |
| Domain | DOCK_N | 4.82e-04 | 5 | 131 | 2 | IPR032376 | |
| Domain | Glyco_transf_10 | 1.33e-03 | 8 | 131 | 2 | PF00852 | |
| Domain | Glyco_tran_10_N | 1.33e-03 | 8 | 131 | 2 | PF17039 | |
| Domain | Glyco_tran_10_N | 1.33e-03 | 8 | 131 | 2 | IPR031481 | |
| Domain | Glyco_trans_10 | 1.33e-03 | 8 | 131 | 2 | IPR001503 | |
| Pathway | REACTOME_HIV_TRANSCRIPTION_INITIATION | 2.73e-05 | 47 | 107 | 5 | M29568 | |
| Pathway | REACTOME_REGULATION_OF_TNFR1_SIGNALING | 2.73e-05 | 47 | 107 | 5 | MM15179 | |
| Pathway | KEGG_RNA_POLYMERASE | 6.44e-05 | 29 | 107 | 4 | M1724 | |
| Pathway | REACTOME_TNF_SIGNALING | 6.44e-05 | 56 | 107 | 5 | MM15453 | |
| Pathway | REACTOME_TNF_SIGNALING | 7.02e-05 | 57 | 107 | 5 | M27713 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 7.39e-05 | 30 | 107 | 4 | M27762 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 7.39e-05 | 30 | 107 | 4 | MM15507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER | 8.43e-05 | 31 | 107 | 4 | M47825 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 1.32e-04 | 65 | 107 | 5 | MM15490 | |
| Pathway | REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME | 1.88e-04 | 70 | 107 | 5 | M27008 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 3.19e-04 | 18 | 107 | 3 | MM15680 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 3.31e-04 | 79 | 107 | 5 | M27742 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 3.72e-04 | 81 | 107 | 5 | M865 | |
| Pathway | REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT | 3.77e-04 | 19 | 107 | 3 | M27020 | |
| Pathway | WP_PYRIMIDINE_METABOLISM | 4.40e-04 | 84 | 107 | 5 | M48340 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE | 4.72e-04 | 48 | 107 | 4 | MM15424 | |
| Pathway | REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS | 5.12e-04 | 21 | 107 | 3 | M27917 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 5.65e-04 | 135 | 107 | 6 | M15247 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 5.89e-04 | 22 | 107 | 3 | MM15675 | |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 6.74e-04 | 23 | 107 | 3 | M1003 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 8.39e-04 | 6 | 107 | 2 | M47967 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 8.66e-04 | 25 | 107 | 3 | M41829 | |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 8.66e-04 | 25 | 107 | 3 | MM15646 | |
| Pathway | KEGG_PYRIMIDINE_METABOLISM | 8.90e-04 | 98 | 107 | 5 | M5109 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 9.48e-04 | 149 | 107 | 6 | M4076 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 1.17e-03 | 7 | 107 | 2 | M47873 | |
| Pathway | REACTOME_PEROXISOMAL_PROTEIN_IMPORT | 1.32e-03 | 63 | 107 | 4 | M27915 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 1.49e-03 | 30 | 107 | 3 | M41825 | |
| Pathway | REACTOME_PEROXISOMAL_PROTEIN_IMPORT | 1.49e-03 | 65 | 107 | 4 | MM15628 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 1.55e-03 | 8 | 107 | 2 | MM1582 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.55e-03 | 8 | 107 | 2 | MM14656 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.55e-03 | 8 | 107 | 2 | M27006 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 6.91e-10 | 26 | 136 | 6 | 26949039 | |
| Pubmed | Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations. | 3.58e-09 | 16 | 136 | 5 | 25723849 | |
| Pubmed | The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. | 7.76e-09 | 7 | 136 | 4 | 21685362 | |
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 30884854 | ||
| Pubmed | 9.45e-09 | 19 | 136 | 5 | 27425610 | ||
| Pubmed | Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. | 1.55e-08 | 8 | 136 | 4 | 23560854 | |
| Pubmed | 1.55e-08 | 8 | 136 | 4 | 29323787 | ||
| Pubmed | The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway. | 2.70e-08 | 23 | 136 | 5 | 30017913 | |
| Pubmed | TRAF-interacting protein (TRIP) is a RING-dependent ubiquitin ligase. | 2.78e-08 | 9 | 136 | 4 | 17544371 | |
| Pubmed | 3.40e-08 | 24 | 136 | 5 | 24647965 | ||
| Pubmed | Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. | 4.24e-08 | 25 | 136 | 5 | 17597759 | |
| Pubmed | 4.61e-08 | 10 | 136 | 4 | 31087003 | ||
| Pubmed | 4.61e-08 | 10 | 136 | 4 | 28757353 | ||
| Pubmed | The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. | 5.23e-08 | 26 | 136 | 5 | 20061386 | |
| Pubmed | Identification of a family of closely related human ubiquitin conjugating enzymes. | 5.85e-08 | 3 | 136 | 3 | 8530467 | |
| Pubmed | Real-time tracking of complex ubiquitination cascades using a fluorescent confocal on-bead assay. | 6.40e-08 | 27 | 136 | 5 | 30097011 | |
| Pubmed | E1-E2 interactions in ubiquitin and Nedd8 ligation pathways. | 1.08e-07 | 12 | 136 | 4 | 22069333 | |
| Pubmed | The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. | 1.08e-07 | 12 | 136 | 4 | 24211586 | |
| Pubmed | Ubiquitination of STING at lysine 224 controls IRF3 activation. | 1.56e-07 | 13 | 136 | 4 | 28763789 | |
| Pubmed | 2.17e-07 | 14 | 136 | 4 | 36481767 | ||
| Pubmed | [New genes on human chromosome 7: bioinformatic analysis of a gene cluster from the POLR2J family]. | 2.33e-07 | 4 | 136 | 3 | 15586814 | |
| Pubmed | A human RNA polymerase II subunit is encoded by a recently generated multigene family. | 2.33e-07 | 4 | 136 | 3 | 11747469 | |
| Pubmed | Physical and functional interactions between ZIP kinase and UbcH5. | 2.33e-07 | 4 | 136 | 3 | 18515077 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 DNAJA2 PKD1L1 RGPD1 CEP192 CLIP1 MEN1 PLEKHG1 OCIAD1 ALMS1 MTUS1 CAPN7 PIN4 COBL MGA CNOT1 | 2.52e-07 | 853 | 136 | 16 | 28718761 |
| Pubmed | 4.39e-07 | 39 | 136 | 5 | 8946909 | ||
| Pubmed | Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. | 4.39e-07 | 39 | 136 | 5 | 9054383 | |
| Pubmed | Three transitions in the RNA polymerase II transcription complex during initiation. | 4.39e-07 | 39 | 136 | 5 | 9405375 | |
| Pubmed | 5.01e-07 | 40 | 136 | 5 | 2449431 | ||
| Pubmed | 5.01e-07 | 40 | 136 | 5 | 1939271 | ||
| Pubmed | 5.12e-07 | 17 | 136 | 4 | 33650289 | ||
| Pubmed | 5.12e-07 | 17 | 136 | 4 | 36563856 | ||
| Pubmed | E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1). | 5.82e-07 | 5 | 136 | 3 | 15684077 | |
| Pubmed | Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair. | 5.82e-07 | 5 | 136 | 3 | 26502057 | |
| Pubmed | Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal. | 5.82e-07 | 5 | 136 | 3 | 25327252 | |
| Pubmed | The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. | 5.82e-07 | 5 | 136 | 3 | 14562029 | |
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 23408431 | ||
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 19741096 | ||
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 8090726 | ||
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 16413270 | ||
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 31929179 | ||
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 12036295 | ||
| Pubmed | Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesis. | 5.82e-07 | 5 | 136 | 3 | 23509263 | |
| Pubmed | Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. | 1.02e-06 | 46 | 136 | 5 | 8849451 | |
| Pubmed | Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. | 1.16e-06 | 6 | 136 | 3 | 22124327 | |
| Pubmed | h-Goliath, paralog of GRAIL, is a new E3 ligase protein, expressed in human leukocytes. | 1.16e-06 | 6 | 136 | 3 | 16549277 | |
| Pubmed | The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2. | 1.16e-06 | 6 | 136 | 3 | 25701873 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 30404641 | ||
| Pubmed | Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination. | 1.16e-06 | 6 | 136 | 3 | 27678051 | |
| Pubmed | Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. | 1.16e-06 | 6 | 136 | 3 | 15280377 | |
| Pubmed | Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114. | 1.16e-06 | 6 | 136 | 3 | 28625874 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 18799729 | ||
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 33962630 | ||
| Pubmed | c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. | 1.27e-06 | 21 | 136 | 4 | 21113135 | |
| Pubmed | FLNA FLNB PSAT1 HSDL2 POLR2A DNAJA2 ADAR LAP3 MEN1 PNPT1 UBE2D2 CNOT1 | 1.37e-06 | 534 | 136 | 12 | 35032548 | |
| Pubmed | RASA2 HSDL2 RGPD1 MUC16 WDR19 PARP4 PBRM1 NXF5 SUGP1 C5 CNOT1 CDH17 AHNAK2 | 1.45e-06 | 638 | 136 | 13 | 31182584 | |
| Pubmed | HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | 1.52e-06 | 90 | 136 | 6 | 35671810 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.85e-06 | 146 | 136 | 7 | 23892456 | |
| Pubmed | A ubiquitin ligase complex assembles linear polyubiquitin chains. | 2.02e-06 | 7 | 136 | 3 | 17006537 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 24831002 | ||
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 17719635 | ||
| Pubmed | RNF122: a novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand. | 2.02e-06 | 7 | 136 | 3 | 20553626 | |
| Pubmed | The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu. | 2.02e-06 | 7 | 136 | 3 | 25278022 | |
| Pubmed | Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate. | 2.02e-06 | 7 | 136 | 3 | 20347421 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 20051513 | ||
| Pubmed | Measuring rates of ubiquitin chain formation as a functional readout of ligase activity. | 2.02e-06 | 7 | 136 | 3 | 22350887 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 34057440 | ||
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 33282879 | ||
| Pubmed | 2.24e-06 | 24 | 136 | 4 | 23827503 | ||
| Pubmed | Reconstitution of human CMG helicase ubiquitylation by CUL2LRR1 and multiple E2 enzymes. | 2.24e-06 | 24 | 136 | 4 | 34195792 | |
| Pubmed | The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. | 2.65e-06 | 25 | 136 | 4 | 19240132 | |
| Pubmed | Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase. | 3.23e-06 | 8 | 136 | 3 | 28681414 | |
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 28972136 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 18838541 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 25207814 | ||
| Pubmed | A novel route for F-box protein-mediated ubiquitination links CHIP to glycoprotein quality control. | 3.23e-06 | 8 | 136 | 3 | 16682404 | |
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 12670957 | ||
| Pubmed | Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. | 3.23e-06 | 8 | 136 | 3 | 15247280 | |
| Pubmed | Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. | 3.23e-06 | 8 | 136 | 3 | 14661060 | |
| Pubmed | DOCK4 SPIRE2 VPS72 RBMS2 DNAJA2 ARHGAP4 C3P1 JRK USP4 TAF4B PLEKHH2 TAF10 MGA | 3.37e-06 | 689 | 136 | 13 | 36543142 | |
| Pubmed | Functional interactions between ubiquitin E2 enzymes and TRIM proteins. | 3.66e-06 | 27 | 136 | 4 | 21143188 | |
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 26711259 | ||
| Pubmed | Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. | 4.83e-06 | 9 | 136 | 3 | 12525502 | |
| Pubmed | Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. | 4.83e-06 | 9 | 136 | 3 | 17460044 | |
| Pubmed | Comparison of Cross-Regulation by Different OTUB1:E2 Complexes. | 4.83e-06 | 9 | 136 | 3 | 32049508 | |
| Pubmed | Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. | 6.48e-06 | 31 | 136 | 4 | 25527291 | |
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 33607208 | ||
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 37345264 | ||
| Pubmed | Bag1 directly routes immature BCR-ABL for proteasomal degradation. | 6.88e-06 | 10 | 136 | 3 | 20675402 | |
| Pubmed | E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP. | 6.88e-06 | 10 | 136 | 3 | 21518764 | |
| Pubmed | 7.41e-06 | 253 | 136 | 8 | 29911972 | ||
| Pubmed | Structural and functional consequences of NEDD8 phosphorylation. | 8.38e-06 | 70 | 136 | 5 | 34642328 | |
| Pubmed | FLNA DSC1 HSDL2 VWA8 POLR2A DNAJA2 CLIP1 PNPT1 JRK COBL PLEKHH2 MGA SEC13 | 8.85e-06 | 754 | 136 | 13 | 35906200 | |
| Pubmed | A dimer-monomer switch controls CHIP-dependent substrate ubiquitylation and processing. | 9.43e-06 | 11 | 136 | 3 | 36027913 | |
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 24438103 | ||
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 19712108 | ||
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 22334663 | ||
| Pubmed | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. | 1.03e-05 | 73 | 136 | 5 | 21729782 | |
| Pubmed | 1.25e-05 | 12 | 136 | 3 | 24905733 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20705653 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 26912277 | ||
| Interaction | ARK2C interactions | 8.36e-07 | 12 | 132 | 4 | int:ARK2C | |
| Interaction | UVSSA interactions | 4.12e-06 | 37 | 132 | 5 | int:UVSSA | |
| Interaction | RNF150 interactions | 7.85e-06 | 20 | 132 | 4 | int:RNF150 | |
| Interaction | RNF25 interactions | 8.81e-06 | 43 | 132 | 5 | int:RNF25 | |
| Interaction | UBOX5 interactions | 1.41e-05 | 23 | 132 | 4 | int:UBOX5 | |
| Interaction | TRIM10 interactions | 1.53e-05 | 48 | 132 | 5 | int:TRIM10 | |
| Interaction | RNF216 interactions | 2.27e-05 | 52 | 132 | 5 | int:RNF216 | |
| Interaction | POLM interactions | 2.35e-05 | 26 | 132 | 4 | int:POLM | |
| Interaction | TRIM43 interactions | 2.49e-05 | 53 | 132 | 5 | int:TRIM43 | |
| Interaction | AREL1 interactions | 2.75e-05 | 27 | 132 | 4 | int:AREL1 | |
| Interaction | MYLIP interactions | 3.26e-05 | 56 | 132 | 5 | int:MYLIP | |
| Interaction | RNF103 interactions | 3.68e-05 | 29 | 132 | 4 | int:RNF103 | |
| Interaction | CADPS2 interactions | 4.22e-05 | 30 | 132 | 4 | int:CADPS2 | |
| Interaction | RNF13 interactions | 4.57e-05 | 60 | 132 | 5 | int:RNF13 | |
| Interaction | CARD8 interactions | 4.57e-05 | 60 | 132 | 5 | int:CARD8 | |
| Interaction | TRIM62 interactions | 5.48e-05 | 32 | 132 | 4 | int:TRIM62 | |
| Interaction | BIRC8 interactions | 5.48e-05 | 32 | 132 | 4 | int:BIRC8 | |
| Interaction | TRIM45 interactions | 6.21e-05 | 33 | 132 | 4 | int:TRIM45 | |
| Interaction | NUP43 interactions | FLNA DSC1 VPS72 HSDL2 DNAJA2 CCDC168 PBRM1 RECQL5 PARN MGA RPL3 CNOT1 AHNAK2 SEC13 | 6.23e-05 | 625 | 132 | 14 | int:NUP43 |
| Interaction | CNOT4 interactions | 6.73e-05 | 65 | 132 | 5 | int:CNOT4 | |
| Interaction | TRIM17 interactions | 7.00e-05 | 34 | 132 | 4 | int:TRIM17 | |
| Interaction | DTX3 interactions | 7.80e-05 | 108 | 132 | 6 | int:DTX3 | |
| Interaction | DTX1 interactions | 7.87e-05 | 35 | 132 | 4 | int:DTX1 | |
| Interaction | ZNRF1 interactions | 8.80e-05 | 36 | 132 | 4 | int:ZNRF1 | |
| Interaction | HECW1 interactions | 9.82e-05 | 37 | 132 | 4 | int:HECW1 | |
| Interaction | UBTD1 interactions | 1.34e-04 | 40 | 132 | 4 | int:UBTD1 | |
| Interaction | RNF122 interactions | 1.45e-04 | 16 | 132 | 3 | int:RNF122 | |
| Interaction | HECTD3 interactions | 1.46e-04 | 121 | 132 | 6 | int:HECTD3 | |
| Interaction | RMND5A interactions | 1.51e-04 | 174 | 132 | 7 | int:RMND5A | |
| Interaction | BRCA1 interactions | DOCK4 FLNA FLNB POLR2A DNAJA2 POLR2J OLA1 FANCM CLIP1 THOC6 PARP4 UBE2D1 UBE2D2 UBE2D3 ALMS1 ABRAXAS1 RECQL5 RPL3 CNOT1 SEC13 | 1.81e-04 | 1249 | 132 | 20 | int:BRCA1 |
| Interaction | RFWD3 interactions | 1.81e-04 | 80 | 132 | 5 | int:RFWD3 | |
| Interaction | GOLGA1 interactions | 2.06e-04 | 183 | 132 | 7 | int:GOLGA1 | |
| Interaction | SPATA25 interactions | 2.09e-04 | 18 | 132 | 3 | int:SPATA25 | |
| Interaction | NR3C1 interactions | FNIP2 DOCK3 RASA2 HSDL2 DNAJA2 RGPD1 MUC16 WDR19 PARP4 PBRM1 NXF5 SUGP1 FNIP1 C5 CNOT1 CDH17 AHNAK2 | 2.13e-04 | 974 | 132 | 17 | int:NR3C1 |
| Interaction | HERC5 interactions | 2.15e-04 | 245 | 132 | 8 | int:HERC5 | |
| Interaction | MKRN2 interactions | ATRX RBMS2 CEP192 UBE2D1 UBE2D2 ALMS1 UBE2D4 TAF1 PLEKHH2 CNOT1 | 2.28e-04 | 385 | 132 | 10 | int:MKRN2 |
| Interaction | MEX3C interactions | 2.28e-04 | 84 | 132 | 5 | int:MEX3C | |
| Interaction | TRIM38 interactions | 2.52e-04 | 47 | 132 | 4 | int:TRIM38 | |
| Interaction | ZNRF2 interactions | 2.52e-04 | 47 | 132 | 4 | int:ZNRF2 | |
| Interaction | RNF10 interactions | 2.69e-04 | 87 | 132 | 5 | int:RNF10 | |
| Interaction | BFAR interactions | 2.74e-04 | 48 | 132 | 4 | int:BFAR | |
| Interaction | PHLDA2 interactions | 2.89e-04 | 20 | 132 | 3 | int:PHLDA2 | |
| Interaction | TRIM50 interactions | 2.97e-04 | 49 | 132 | 4 | int:TRIM50 | |
| Interaction | RNF14 interactions | 2.97e-04 | 49 | 132 | 4 | int:RNF14 | |
| Interaction | TAF8 interactions | 3.21e-04 | 50 | 132 | 4 | int:TAF8 | |
| Interaction | TAF11 interactions | 3.46e-04 | 51 | 132 | 4 | int:TAF11 | |
| Interaction | UHRF2 interactions | 3.53e-04 | 200 | 132 | 7 | int:UHRF2 | |
| Interaction | RING1 interactions | 3.64e-04 | 201 | 132 | 7 | int:RING1 | |
| Cytoband | 9q33-q34 | 5.13e-05 | 4 | 135 | 2 | 9q33-q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 6.14e-04 | 797 | 135 | 9 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q21 | 6.64e-04 | 133 | 135 | 4 | chr4q21 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 2.21e-06 | 41 | 94 | 5 | 102 | |
| GeneFamily | RNA polymerase subunits | 1.47e-05 | 29 | 94 | 4 | 726 | |
| GeneFamily | Taste 2 receptors | 1.09e-03 | 39 | 94 | 3 | 1162 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.43e-03 | 11 | 94 | 2 | 1168 | |
| GeneFamily | THAP domain containing | 1.71e-03 | 12 | 94 | 2 | 65 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 2.01e-03 | 13 | 94 | 2 | 434 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.59e-07 | 199 | 135 | 9 | M5893 | |
| Coexpression | GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN | 8.99e-06 | 198 | 135 | 8 | M6190 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | FLNB TRAF1 DNAJA2 RGPD1 CEMIP2 PNPT1 AREL1 MTUS1 PRPF4 ENG NOS2 | 1.64e-05 | 435 | 135 | 11 | MM1221 |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 8.00e-09 | 193 | 135 | 9 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.00e-09 | 193 | 135 | 9 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.17e-07 | 189 | 135 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.17e-07 | 189 | 135 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.27e-07 | 191 | 135 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 195 | 135 | 8 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 2.02e-06 | 192 | 135 | 7 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.16e-06 | 194 | 135 | 7 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 195 | 135 | 7 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-06 | 196 | 135 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.47e-06 | 198 | 135 | 7 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 9.47e-06 | 160 | 135 | 6 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 168 | 135 | 6 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 168 | 135 | 6 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 170 | 135 | 6 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 1.43e-05 | 172 | 135 | 6 | c3822ff7329c3ac38c68c5c38cd67c390682e2a6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-05 | 178 | 135 | 6 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.79e-05 | 179 | 135 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.22e-05 | 186 | 135 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.29e-05 | 187 | 135 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.36e-05 | 188 | 135 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 189 | 135 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.51e-05 | 190 | 135 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 135 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.58e-05 | 191 | 135 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.74e-05 | 193 | 135 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-05 | 193 | 135 | 6 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-05 | 193 | 135 | 6 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.74e-05 | 193 | 135 | 6 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.74e-05 | 193 | 135 | 6 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 193 | 135 | 6 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 2.82e-05 | 194 | 135 | 6 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.90e-05 | 195 | 135 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 196 | 135 | 6 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 196 | 135 | 6 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.98e-05 | 196 | 135 | 6 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 196 | 135 | 6 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 196 | 135 | 6 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 197 | 135 | 6 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 197 | 135 | 6 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 197 | 135 | 6 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 197 | 135 | 6 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 198 | 135 | 6 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 3.25e-05 | 199 | 135 | 6 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | 367C-Endothelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 199 | 135 | 6 | 636ff80938907f137e955388797072ab45289062 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.25e-05 | 199 | 135 | 6 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.04e-05 | 141 | 135 | 5 | 330f944b38c3170dfc79ab033fae7b9ab71e840d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 7.28e-05 | 142 | 135 | 5 | 0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 159 | 135 | 5 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.56e-04 | 167 | 135 | 5 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 167 | 135 | 5 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.65e-04 | 169 | 135 | 5 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 170 | 135 | 5 | 52fdf93c2803fecb2a640ef4e0b257786f3d4cb1 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.69e-04 | 170 | 135 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 170 | 135 | 5 | 263e98aa1c49493cc262b2608c6582930841cb10 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.74e-04 | 171 | 135 | 5 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 171 | 135 | 5 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 171 | 135 | 5 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 172 | 135 | 5 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | ASK454-Epithelial-Transformed_epithelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.79e-04 | 172 | 135 | 5 | 3986f0f098ef5e096c8d9ee3d335b8404083701f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 173 | 135 | 5 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 173 | 135 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 173 | 135 | 5 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 174 | 135 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Tuft-tuft-4|World / Class top | 1.89e-04 | 174 | 135 | 5 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 177 | 135 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 177 | 135 | 5 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.10e-04 | 178 | 135 | 5 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.21e-04 | 180 | 135 | 5 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.27e-04 | 181 | 135 | 5 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 181 | 135 | 5 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 181 | 135 | 5 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 181 | 135 | 5 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 182 | 135 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-04 | 182 | 135 | 5 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 182 | 135 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.32e-04 | 182 | 135 | 5 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 183 | 135 | 5 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 183 | 135 | 5 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 183 | 135 | 5 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | Healthy-CD8+_T_naive|Healthy / disease group, cell group and cell class | 2.38e-04 | 183 | 135 | 5 | 5e7a611cfb8a21106bb07361878ccc77ff251502 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 183 | 135 | 5 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3|World / Primary Cells by Cluster | 2.44e-04 | 184 | 135 | 5 | 907ba412166bcb0526c5be0b06a76b6bd37c5a35 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.44e-04 | 184 | 135 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.51e-04 | 185 | 135 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-04 | 185 | 135 | 5 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 2.51e-04 | 185 | 135 | 5 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 186 | 135 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.63e-04 | 187 | 135 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-04 | 187 | 135 | 5 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.63e-04 | 187 | 135 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-04 | 187 | 135 | 5 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.63e-04 | 187 | 135 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.63e-04 | 187 | 135 | 5 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-04 | 188 | 135 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-04 | 188 | 135 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-04 | 188 | 135 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| Computational | Genes in the cancer module 4. | 1.71e-05 | 21 | 82 | 4 | MODULE_4 | |
| Computational | Genes in the cancer module 233. | 2.07e-05 | 22 | 82 | 4 | MODULE_233 | |
| Computational | Genes in the cancer module 82. | 2.98e-05 | 24 | 82 | 4 | MODULE_82 | |
| Disease | alcohol and nicotine codependence | 2.01e-05 | 13 | 124 | 3 | EFO_0004776 | |
| Disease | Pancreatic Endocrine Carcinoma | 5.24e-05 | 3 | 124 | 2 | C1328479 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 6.68e-05 | 19 | 124 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | X-12125 measurement | 1.05e-04 | 4 | 124 | 2 | EFO_0800707 | |
| Disease | Cis-4-decenoyl carnitine measurement | 1.74e-04 | 5 | 124 | 2 | EFO_0022091 | |
| Disease | pulse pressure measurement | FLNB FUT10 TRAF1 CYP2C9 PLEKHG1 PNPT1 AREL1 FNDC1 PBRM1 PPP1R1C SYT4 PCOLCE2 HHIPL1 CNOT1 HYDIN CDH17 | 2.46e-04 | 1392 | 124 | 16 | EFO_0005763 |
| Disease | serum galactose-deficient IgA1 measurement | 2.60e-04 | 6 | 124 | 2 | EFO_0007947 | |
| Disease | X-11787 measurement | 4.82e-04 | 8 | 124 | 2 | EFO_0021258 | |
| Disease | N2,N2-dimethylguanosine measurement | 4.82e-04 | 8 | 124 | 2 | EFO_0021125 | |
| Disease | osteoarthritis, spine, body mass index | 4.82e-04 | 8 | 124 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | octanoylcarnitine measurement | 6.19e-04 | 9 | 124 | 2 | EFO_0021042 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 7.38e-04 | 42 | 124 | 3 | DOID:612 (is_implicated_in) | |
| Disease | Neuroendocrine Tumors | 9.40e-04 | 11 | 124 | 2 | C0206754 | |
| Disease | Hamman-Rich syndrome | 1.54e-03 | 14 | 124 | 2 | C0085786 | |
| Disease | cranial vault morphology measurement | 1.73e-03 | 121 | 124 | 4 | EFO_0009278 | |
| Disease | cancer biomarker measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0005127 | |
| Disease | N-acetylmethionine measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0021427 | |
| Disease | Malignant neoplasm of breast | FLNA FLNB DDX59 VPS72 OLA1 PLEKHD1 ADAR CLIP1 PBRM1 PER3 ABRAXAS1 NOS2 | 1.93e-03 | 1074 | 124 | 12 | C0006142 |
| Disease | alcoholic liver cirrhosis | 2.29e-03 | 17 | 124 | 2 | EFO_1000802 | |
| Disease | Global developmental delay | 2.44e-03 | 133 | 124 | 4 | C0557874 | |
| Disease | alpha synuclein measurement | 2.56e-03 | 18 | 124 | 2 | EFO_0009323 | |
| Disease | Usual Interstitial Pneumonia | 2.86e-03 | 19 | 124 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.86e-03 | 19 | 124 | 2 | C4721508 | |
| Disease | age-related macular degeneration, COVID-19 | 3.10e-03 | 69 | 124 | 3 | EFO_0001365, MONDO_0100096 | |
| Disease | citrulline measurement | 3.17e-03 | 20 | 124 | 2 | EFO_0009777 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.17e-03 | 20 | 124 | 2 | C4721952 | |
| Disease | skin hydration measurement | 3.49e-03 | 21 | 124 | 2 | EFO_0009586 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.49e-03 | 21 | 124 | 2 | C1800706 | |
| Disease | gamma-glutamylglutamine measurement | 3.83e-03 | 22 | 124 | 2 | EFO_0021138 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HSLYKPQKGLFHRVP | 151 | Q6UWZ7 | |
| KEHLSPVVTAYFQKP | 71 | Q9BYV1 | |
| IQELAPKYAATHPKT | 171 | Q49AH0 | |
| GPPFHLKKYSVAQQC | 256 | Q969M2 | |
| KPIVIYKQAFPEGHL | 1481 | Q8TCU4 | |
| KPIVNYKQAFPDGHL | 1576 | Q8TCU4 | |
| KYINYTFPKLSPGHA | 291 | Q5TEZ5 | |
| SFLLHFYTVPIPKTG | 531 | P17813 | |
| IITHFNGKYIKTPPG | 191 | Q15434 | |
| VIQHFNGKYLKTPPG | 196 | Q6XE24 | |
| HKQPGSKDAIYTIPV | 641 | Q15283 | |
| QYHKPASKIPAFLNV | 76 | Q9NTK5 | |
| FIPNHLPFKLEKTYG | 386 | Q9Y5H2 | |
| YLGSFLSPPKIHVSA | 396 | O95453 | |
| PDPLTLYHKGIASAK | 301 | O00255 | |
| PPLKAGKTRTFYGLH | 76 | P28838 | |
| VHTAYSRLPGKPKVY | 1041 | P35228 | |
| KFYVHIKPAPARAPA | 356 | O14526 | |
| LKPLFKNTSVGPLYS | 12266 | Q8WXI7 | |
| ASVIYLKPKGPHSQE | 256 | O60403 | |
| GQLIAEPFYHLPSKK | 401 | Q86U86 | |
| KPSGKIVYNITLPLH | 1496 | Q86XX4 | |
| YPKSRVLKFSPGVDH | 3091 | Q86XX4 | |
| YPVSPKQKYSHVILG | 921 | Q8IWI9 | |
| LLPIFAYPHTVGKSV | 461 | Q96JK4 | |
| PALVGTEKPKYLQHS | 106 | Q9ULD2 | |
| KNYGVLHVTFPLLFP | 816 | P59045 | |
| DPYLKISIQPGKHSI | 226 | Q76N89 | |
| KNYHVEVLIPPSISK | 2631 | Q8NDA2 | |
| GLHSLAFKSYKPEIQ | 706 | Q5HYC2 | |
| LSPGYSQFSLPVQKK | 1321 | Q8IYD8 | |
| HNLKKSGYEVPTPIQ | 216 | Q5T1V6 | |
| VAPFGYLKIHRLKPS | 926 | Q8N6G6 | |
| LVKYNDKHIPGSPFT | 1891 | O75369 | |
| KITRNFYVDGHVPKP | 171 | Q6P4F2 | |
| AIHQKVLKYAGHPPF | 321 | P56645 | |
| FTDPPVKTKFGYHII | 111 | Q9Y237 | |
| PRAFKGIQHLPVAYK | 241 | O75564 | |
| SHFTAPYSVKNKLKP | 86 | Q9H1B4 | |
| LPQSYHTPIKDKVFS | 261 | Q8NHC8 | |
| KHFALTFPKPLQRGT | 31 | P35663 | |
| YAQSKPISPKLLSHF | 291 | Q9H4H8 | |
| AKTAQPHPKLLGTIY | 41 | Q6YN16 | |
| SFLHQYTGSFKKPPL | 56 | Q00537 | |
| FIGHYIFRPKKLPTT | 261 | Q9UKZ9 | |
| TNKSHVPIEAKYIFP | 646 | Q9UKK3 | |
| PHLFPSFTKLTNIYK | 251 | Q2PPJ7 | |
| PKDQGPTYLLIGSKH | 891 | Q8IVE3 | |
| FLAEHKYPTLPGKLS | 416 | Q8ND30 | |
| ILSSHPKYGSIPKLI | 66 | Q9NX40 | |
| ALVAHKYDFKLSLPP | 331 | Q6GPH6 | |
| FKHLDGRQIVVKYPP | 286 | O60884 | |
| TALTKFLPPKHEYVL | 1821 | P46100 | |
| GLHLYFQPTKPVNIK | 2996 | Q4G0P3 | |
| PNVKGIFPANYIHLK | 51 | Q8IZD9 | |
| PNIKGIFPSSYVHLK | 51 | Q8N1I0 | |
| SRHYPVFENPKQGKL | 986 | P55265 | |
| GPKIAFYVGLKSPHE | 156 | Q7Z5L3 | |
| FTLPKSKSGISHYPI | 16 | Q6ZMU1 | |
| SKSGISHYPISVKVP | 21 | Q6ZMU1 | |
| PHYLTKIKLTTPGTH | 636 | Q9Y6W3 | |
| LQPGKKHPTVLFVYG | 631 | Q86TI2 | |
| TVSVKYKGQHVPGSP | 2211 | P21333 | |
| SPKNNYKLFHKPVIT | 151 | Q6P4F1 | |
| ILSYAPALKPFGAKS | 396 | Q4ZHG4 | |
| YKGSTLKIHQIRSPP | 141 | Q8TF40 | |
| KGSTLKIHYIRSPPQ | 151 | Q9P278 | |
| HLNIIVTPKSPYIDK | 481 | P01031 | |
| VTPKSPYIDKITHYN | 486 | P01031 | |
| LTPAFHFNILKPYIK | 151 | P98187 | |
| QSHPQKPFYTVGEKV | 641 | P10643 | |
| LKHGLTTYKIIPPKS | 701 | O75128 | |
| PVVPKATYGLKHAES | 191 | Q9H3Q1 | |
| PSPFSGNIYHILGKV | 1001 | Q5TEA3 | |
| VGHVFPKQAPYSRNK | 361 | Q8IXK2 | |
| KFSYLGPDPVHKLLT | 386 | O15033 | |
| GPIHLTRSTFKKYVP | 876 | Q9UHN6 | |
| LKVDVYGRSHKPLPQ | 216 | P51993 | |
| LYSILQHKGLVDKFP | 306 | P21695 | |
| HSLKFLSPREPFYVK | 2471 | Q8TEP8 | |
| DLPNTPHSKAVYKIL | 381 | Q08554 | |
| PYFVTPNLHGILIKK | 696 | Q8NCS7 | |
| YPKTQHKSLLEQFTP | 6396 | Q8NDH2 | |
| PIIDYFPGTHNKLLK | 221 | P11712 | |
| PHTNTGYVIIKKPLD | 506 | Q12864 | |
| PSLYSLKNVPEHLAK | 1046 | Q8IZU8 | |
| ISQLILFKKNPYPGS | 1511 | Q8TDX9 | |
| AIKPYLALKGSVAFP | 101 | P20382 | |
| QPKYGLFAPVHKVTK | 266 | P30622 | |
| LFAPVHKVTKIGFPS | 271 | P30622 | |
| IPHYTSLKPSKNFEI | 86 | Q6J272 | |
| VYPHTPTSFKVKDIN | 431 | P42702 | |
| FPGSPAIYKLKEHLL | 116 | P0DJD0 | |
| LFAGYKVPHPLEHKI | 56 | Q9H1A7 | |
| SLIDHPSGQKPNYIK | 166 | P55735 | |
| NKTPPYKFVHVLKGV | 46 | Q9H2B2 | |
| YPSTHPFILILGNKK | 271 | P59541 | |
| YPSTHPFILILGNKK | 271 | P0DTE0 | |
| YPSTHPFILIWGNKK | 271 | P59540 | |
| KLYVELKSSPQPHLV | 306 | Q92750 | |
| TPALSEYGINVKKPH | 201 | Q12962 | |
| DPSKPVHLTAFLGYK | 36 | P39023 | |
| VAPVVKKPHIYYGSL | 21 | O43172 | |
| HRPPLKKYSFGALSQ | 616 | P21675 | |
| NTYPFHTPVNAKVVK | 1401 | P21675 | |
| QSVYTPPTIKGVKHL | 71 | Q8WVI7 | |
| INIVHPKLGSYTKIP | 121 | Q9Y617 | |
| TAAYELLHFPKVFPK | 236 | Q9Y274 | |
| STKVPFAHKPLLLYN | 601 | Q8NEZ3 | |
| PNSKLKGLTFHVFPT | 16 | Q8TBB0 | |
| LFTPSPEIVKYTHKL | 276 | Q8TCS8 | |
| PHKYITLPAGTEKQV | 796 | P98171 | |
| VPFHGKTFILKTFLP | 276 | Q14849 | |
| YGFSLLKVKIPEPHT | 5516 | Q8IVF2 | |
| ILNSYTKIAPHPGKR | 156 | Q9C0C6 | |
| YQKSLKPAPHLFAQL | 101 | A5YKK6 | |
| LFAGYKVPHPLEHKI | 56 | Q9GZM3 | |
| HVYSLKPKRVGAGFP | 646 | O94762 | |
| GPVKSYSHAKQLPVA | 141 | Q8IWZ8 | |
| NFPKRHFLIPTSYKG | 326 | Q8N1K5 | |
| PYLHGGIAVQVKTPK | 281 | A0AVT1 | |
| PFKPPKVAFTTRIYH | 61 | P62837 | |
| YGQPLLLSVPKHKLT | 601 | Q13107 | |
| PFYLHDLKVGPKLTL | 1366 | Q9C0A1 | |
| PSVSLYKIPQGVHLK | 86 | Q9H5L6 | |
| LKGPLLPETYSKINH | 531 | Q9H5L6 | |
| ETNKYFNIHPKGVIP | 71 | A6NEE1 | |
| PSKKFGHIPVYTLGF | 606 | Q8WWL2 | |
| LKPGLVYNKVNPIFH | 66 | Q2MJR0 | |
| GPYKHISPGDTKVVV | 616 | P24928 | |
| PFKPPKVAFTTRIYH | 61 | P61077 | |
| KKPVVTFQAHDGPVY | 66 | Q86W42 | |
| LFFPLSKLQSPKHAY | 386 | Q13077 | |
| GQSLPPQKKAYLSHL | 101 | O60290 | |
| PASPPKGYFLTKIFH | 71 | Q16763 | |
| ISVGYHGTKPDLIFK | 51 | P17031 | |
| KHSLPLGSYLLKPVQ | 236 | Q9ULL1 | |
| EAYKKYITAHGLPPT | 321 | Q15906 | |
| LKNYLSPTFKEVIPH | 1266 | Q9NYU1 | |
| PFKPPKVAFTTKIYH | 61 | Q9Y2X8 | |
| PKGAVLYKTFVHVVP | 121 | Q9P0M9 | |
| LYKTFVHVVPAKPEG | 126 | Q9P0M9 | |
| HKYGIPIGAKPTSVQ | 1021 | A3KMH1 | |
| LLFNLPPGSVHYKKL | 201 | Q99990 | |
| LKDPQVLFAGYKVPH | 51 | P52435 | |
| VLFAGYKVPHPLEHK | 56 | P52435 | |
| PFKPPKIAFTTKIYH | 61 | P51668 |